TITLE

Prevention of osteoporosis and osteoporotic fractures in postmenopausal women: recommendation statement from the Canadian Task Force on Preventive Health Care

AUTHOR(S)
Cheung, Angela M.; Feig, Denice S.; Kapral, Moira; Diaz-Granados, Natalia; Dodin, Sylvie
PUB. DATE
May 2004
SOURCE
CMAJ: Canadian Medical Association Journal;5/25/2004, Vol. 170 Issue 11, p1665
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Provides information on osteoporosis and osteoporotic fractures in postmenopausal Canadian women and possible prevention as recommended by the Canadian Task Force on Preventive Health Care. Statistics on White women 50 years of age in Canada who will have an osteoporotic fracture during their remaining lifetime; Conditions of women to which the recommendation of the task force does not apply; Objective of the recommendation; Basis of the of the recommended age for initiation of screening; Unique Feature of the guideline.
ACCESSION #
13118802

 

Related Articles

  • The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women. Mezquita-Raya, Pedro; de la Higuera, Magdalena; García, Diego Fernández; Alonso, Guillermo; Ruiz-Requena, María Estrella; de Dios Luna, Juan; Escobar-Jiménez, Fernando; Muñoz-Torres, Manuel // Osteoporosis International;Nov2005, Vol. 16 Issue 11, p1368 

    Regulation of osteoclastic activity is critical for understanding bone loss associated with the postmenopausal period. In vitro and animal studies have revealed the role of OPG as a decoy receptor that neutralizes the effect of RANKL on the differentiation and activation of osteoclasts. However,...

  • DEXA screening–are we doing too much? Craig, Kevin W.; Stevermer, James J. // Journal of Family Practice;Sep2012, Vol. 61 Issue 9, p555 

    The article presents a study on screening for osteoporosis in postmenopausal women. It says that osteoporosis is the key predictor of fracture risk, and low bone mineral density (BMD) increases the possibility of fracture by 70% to 80%. It states that the U.S. Preventive Services Task Force...

  • Is osteoporosis screening in postmenopausal women effective? Phillips, John; Krist, Alex; Wilder, Laura; Lefevre, Michael L. // Journal of Family Practice;Apr2003, Vol. 52 Issue 4, p331 

    The article evaluates the effectiveness of osteoporosis screening in detecting the likelihood of osteoporotic fracture in postmenopausal women. A prospective observational study conducted among women over 50 years of age revealed that osteoporosis was associated with a fracture rate 4 times that...

  • AADA's New Age of Aging': A new but familiar face. Burlew, Larry D. // Counseling Today;Apr2006, Vol. 48 Issue 10, p38 

    The article focuses on the Association for Adult Development and Aging's (AADA) commitment to providing information about the changes in adult development for the 21st century. The group has formed a Competencies Task Force, charged with exploring these changes and taking a leadership role in...

  • Calcium plus Vitamin D for Postmenopausal Women – Bone Appétit? Finkelstein, Joel S. // New England Journal of Medicine;2/16/2006, Vol. 354 Issue 7, p750 

    The article presents the comments of the author on the efficacy of calcium and vitamin D for the prevention of fractures among post menopausal women. According to the author, the beneficial effect of calcium with vitamin D supplementation is insignificant for women undergoing hormone-replacement...

  • Funding threat to prescribing plan.  // Pulse;5/17/2004, Vol. 64 Issue 20, p17 

    Reports on criticisms against the National Institute for Clinical Excellence for releasing confusing guidelines on the secondary prevention of bone fractures in postmenopausal women. Initial recommendations on osteoporosis.

  • Long-term safety of alendronate established in 10-year study.  // Formulary;May2004, Vol. 39 Issue 5, p249 

    Reports on a study published in a 2004 issue of "The New England Journal of Medicine" indicating that postmenopausal women maintained or increased their bone density and prevented osteoporosis-related fractures through continuous treatment with alendronate daily for ten years. Gradual diminution...

  • Pathogenesis of vertebral crush fractures in women. Caplan, G. A.; Scane, A. C.; Francis, R. M. // Journal of the Royal Society of Medicine;Apr1994, Vol. 87 Issue 4, p200 

    In a series of 214 women with vertebral crush fractures, 119 (55.6%) were found to have either an underlying secondary cause of osteoporosis or an early menopause before the age of 45 or both. A secondary cause of osteoporosis was present in 65 women (30.4%), the most common of which was...

  • The Efficacy and Tolerability of Risedronate Once a week for the Treatment of Postmenopausal Osteoporosis. Brown, J. P.; Kendler, D. L.; McClung, M. R.; Emkey, R. D.; Adachi, J. D.; Bolognese, M. A.; Li, Z.; Balske, A.; Lindsay, R. // Calcified Tissue International;Aug2002, Vol. 71 Issue 2, p103 

    This study evaluated the efficacy and tolerability of risedronate once a week (35 mg and 50 mg) compared with risedronate 5 mg once daily in women with osteoporosis. We conducted a randomized, double-blind, active-controlled, 2-year study; the primary efficacy assessment was performed after 1...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics